No difference in Major Adverse Cardiovascular Events (MACE plus ) with Basal Insulin peglispro (BIL) vs comparator insulins in patients with type 1 or type 2 diabetes
DIABETOLOGIA(2015)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
DIABETOLOGIA(2015)